Genetic mutations and prognostic indicators in differentiated thyroid cancer: a molecular perspective
Turkish Journal of Medical Sciences · 18.02.2025 · 55 (1) · 72-81
DOI: 10.55730/1300-0144.5944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 18.02.2025. Verfasst von Halim Özçevik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Hamidiye Medical Faculty, University of Health Sciences, İstanbul, Turkiye. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: This study aimed to investigate the relationship between the presence of BRAF, HRAS, NRAS, and KRAS gene mutations and the development of dedifferentiation (iodine-refractory disease) and extrathyroidal disease in patients with differentiated thyroid carcinoma (DTC).Materials and methods: Seventy-seven adult patients classified as intermediate and high-risk according to the ATA 2015 guidelines, who underwent total thyroidectomy followed by radioiodine I-131(RAI) therapy between June 2014 and December 2022, were included. Clinical data were collected via the hospital information system, including the number of surgeries, RAI treatments, and levels of thyroglobulin(Tg), anti-thyroglobulin, and thyroid-stimulating hormone. Histopathological subtypes of DTC were re-evaluated, and mutation analyses of BRAF, KRAS, NRAS, and HRAS genes were performed using real-time polymerase chain reaction (PCR). Statistical analyses were conducted using Medcalc software, with p-values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Hamidiye Medical Faculty, University of Health Sciences, İstanbul, Turkiye.
- Department of Nuclear Medicine, Prof. Dr. Cemil Taşcıoğlu City Hospital, University of Health Sciences, İstanbul, Turkiye.
- Department of Pathology, Prof. Dr. Cemil Taşcıoğlu City Hospital, University of Health Sciences, İstanbul, Turkiye.
- Department of Medical Genetics, Prof. Dr. Cemil Taşcıoğlu City Hospital, University of Health Sciences, İstanbul, Turkiye.
ORCID-Profile: Halim Özçevik, Müge Öner Tamam, Gündüzalp Buğrahan Babacan, Selma Şengiz Erhan, Merve Nur Acar Tayyar, Biray Ertürk
Zitieren
APA
Özçevik, H., Öner Tamam, M., Babacan, G. B., Şengiz Erhan, S., Acar Tayyar, M. N., & Ertürk, B. (2025). Genetic mutations and prognostic indicators in differentiated thyroid cancer: a molecular perspective. Turkish Journal of Medical Sciences, 55(1), 72-81. https://doi.org/10.55730/1300-0144.5944
Vancouver
Özçevik H, Öner Tamam M, Babacan GB, Şengiz Erhan S, Acar Tayyar MN, Ertürk B. Genetic mutations and prognostic indicators in differentiated thyroid cancer: a molecular perspective. Turkish Journal of Medical Sciences. 2025;55(1):72-81. doi:10.55730/1300-0144.5944
BibTeX
@article{zevik2025,
author = {Özçevik, Halim and Öner Tamam, Müge and Babacan, Gündüzalp Buğrahan and Şengiz Erhan, Selma and Acar Tayyar, Merve Nur and Ertürk, Biray},
title = {Genetic mutations and prognostic indicators in differentiated thyroid cancer: a molecular perspective},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {1},
pages = {72--81},
doi = {10.55730/1300-0144.5944}
}
EUVIMED